Heska’s second-quarter earnings, revenue drop year-over-year
LOVELAND — Heska Corp. (Nasdaq: HSKA), a provider of advanced veterinary diagnostic and specialty products, reported second-quarter earnings of 24 cents per share, beating analyst expectations by 8 cents.
However, earnings per share were nearly halved year-over-year, from 44 cents during the second quarter of 2017 to 24 cents this quarter. Net income fell from $3.3 million to $1.9 million.
The Loveland-based company posted revenue of $29.7 million, a 11.2 percent decrease from the same period last year and missing analyst expectations by a little less than $500,000.
SPONSORED CONTENT
Federal District Court Rules Corporate Transparency Act Unconstitutional . . . But Most Small Businesses Must Still Comply
Lyons Gaddis Real Estate and Business Attorney Cameron Grant shares important details of the Corporate Transparency Act (CTA).
Heska’s updated outlook for the second half of the year is revenue of $31 million for the third quarter, down from the earlier expectation of $34.6 million. The full-year expectation is revenue of $135 million, down from the earlier forecast of $139 million.
LOVELAND — Heska Corp. (Nasdaq: HSKA), a provider of advanced veterinary diagnostic and specialty products, reported second-quarter earnings of 24 cents per share, beating analyst expectations by 8 cents.
However, earnings per share were nearly halved year-over-year, from 44 cents during the second quarter of 2017 to 24 cents this quarter. Net income fell from $3.3 million to $1.9 million.
The Loveland-based company posted revenue of $29.7 million, a 11.2 percent decrease from the same period last year and missing analyst expectations by a little less than $500,000.
Heska’s updated outlook for the second…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!